United States · FDA National Drug Code directory
cetirizine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59556-894_59c7dbe5-bf71-fd55-e063-6294a90a7635
- Product NDC
- 59556-894
- Form
- CAPSULE, LIQUID FILLED
- Composition / generic term
- cetirizine hydrochloride
- Labeler
- Strides Pharma, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170721
- Source listing expiry
- 20271231
Source-listed ingredients
- CETIRIZINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (59556-894-12) / 40 CAPSULE, LIQUID FILLED in 1 BOTTLE · 59556-894-12
- 1 BOTTLE in 1 CARTON (59556-894-77) / 12 CAPSULE, LIQUID FILLED in 1 BOTTLE · 59556-894-77
- 1 BOTTLE in 1 CARTON (59556-894-78) / 25 CAPSULE, LIQUID FILLED in 1 BOTTLE · 59556-894-78
- 7000 CAPSULE, LIQUID FILLED in 1 BAG (59556-894-79) · 59556-894-79
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →